Sonam Puri, MBBS

Sonam Puri practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Sonam Puri's NPI, 1346675915, was assigned on September 13, 2013. Sonam Puri graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 2011. Sonam Puri holds Florida license ME167326.

Sonam Puri's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Sonam Puri also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Sonam Puri's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is University of Utah Health. Dmand AI also links Sonam Puri to 2 more group practices and clinics, 1 breast imaging center, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sonam Puri practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Sonam Puri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Sonam Puri is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Sonam Puri's licenses on file in 2 states: Florida and Utah.

Dmand AI lists lung cancer among the conditions Sonam Puri treats.

CMS data shows 249 Medicare services from Sonam Puri across 5 procedure codes in 2024, for 87 Medicare patients. Medicare paid $19,512 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Sonam Puri in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sonam Puri's median patient age at 72, with 58% women.

In 2024, Sonam Puri wrote 197 Medicare Part D claims for 56 patients. 80% of them were for generic drugs. CMS names the drug for 98 of them, across 5 drugs with 11 or more claims each, at $162,098 in total drug cost. In 2023, CMS named 213 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Sonam Puri for performance year 2024, reported as part of a group. Sonam Puri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sonam Puri as offering telehealth.

Dmand AI links 38 papers to Sonam Puri, published from 2014 to 2024. 2024 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Immunotherapy. Sonam Puri has published most often in Ann Transl Med. Sonam Puri's most frequent co-authors are Jhanelle E. Gray, MD, Shiven B. Patel, FACP, MBA, MD and Theresa A. Boyle, MD.

Dmand AI links Sonam Puri to 2 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 44 general payments to Sonam Puri from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Novocure Inc. paid the most, $6,429.

Sonam Puri graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 2011.

Sonam Puri is in network with 9 carriers, including Elevance, United Healthcare and Cigna. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.